Earnings Beat Ignites Optimism: Social media erupted following UnitedHealth Group's Q1 earnings, which surpassed expectations with revenue of $111.7 billion and adjusted EPS of $7.23. The company raised its full-year guidance, prompting shares to gap up sharply as investors praised aggressive margin protections and a $2 billion buyback authorization. Discussions highlighted the firm's strategic retreat from unprofitable Medicare segments as a path to sustained growth.
Medicare Boost Fuels Rally: Chatter surged around a government decision to increase Medicare payments to the insurer more than anticipated, driving the stock up over 30% since February. Users pointed to timely purchases by politicians ahead of the announcement, viewing it as validation of insider confidence. The +2.5% reimbursement hike was hailed as a critical tailwind amid broader sector pressures.
Recovery Signs Amid Cautions: Recent analyst upgrades, including Mizuho's $410 target, added to bullish momentum on social media platforms. Yet some traders warned of technical downside risks and lingering DOJ scrutiny, tempering the enthusiasm. Major health insurers' improving fortunes drew comparisons, positioning UnitedHealth at the forefront of a potential rebound.
Note: This discussion summary was generated from an AI condensation of post data.
UnitedHealth Group Revenue
UnitedHealth Group had revenues of $111.7B in Q1 2026. This is an increase of 1.96% from the same period in the prior year.
You can track UNH financials on Quiver Quantitative's UNH stock page.
UnitedHealth Group Congressional Stock Trading
Members of Congress have traded $UNH stock 11 times in the past 6 months. Of those trades, 6 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/19, 11/05 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $65,000 on 03/13, 12/19 and 2 sales worth up to $65,000 on 02/10, 11/12.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/25.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/05.
- REPRESENTATIVE KEVIN HERN sold up to $500,000 on 12/23.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
UnitedHealth Group Hedge Fund Activity
We have seen 1,256 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 1,857 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 20,260,160 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $6,688,081,417
- CAPITAL RESEARCH GLOBAL INVESTORS removed 6,780,251 shares (-52.0%) from their portfolio in Q4 2025, for an estimated $2,238,228,657
- CARDANO RISK MANAGEMENT B.V. removed 2,264,606 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $608,839,323
- CITADEL ADVISORS LLC added 2,079,416 shares (+244.9%) to their portfolio in Q4 2025, for an estimated $686,436,015
- HSBC HOLDINGS PLC added 1,805,008 shares (+46.1%) to their portfolio in Q1 2026, for an estimated $485,276,400
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 1,568,099 shares (+532.9%) to their portfolio in Q4 2025, for an estimated $517,645,160
- AMUNDI added 1,544,066 shares (+26.6%) to their portfolio in Q4 2025, for an estimated $509,711,627
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
UnitedHealth Group Government Contracts
We have seen $16,236,070,750 of award payments to $UNH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: R3 FY25 3RD QTR APRIL: $830,362,703
- EXPRESS REPORT: R3 FY25 3RD QTR MAY: $819,320,444
- EXPRESS REPORT: R3 FY25 2ND QTR MARCH: $791,841,212
- EXPRESS REPORT: R3 FY25 2ND QTR FEBRUARY: $730,504,137
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
UnitedHealth Group Analyst Ratings
Wall Street analysts have issued reports on $UNH in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 02/05/2026
- Truist Securities issued a "Buy" rating on 02/02/2026
- Barclays issued a "Overweight" rating on 01/30/2026
- Wells Fargo issued a "Overweight" rating on 01/30/2026
- Jefferies issued a "Buy" rating on 01/28/2026
- Leerink Partners issued a "Outperform" rating on 01/28/2026
To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.
UnitedHealth Group Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 18 analysts offer price targets for $UNH in the last 6 months, with a median target of $396.0.
Here are some recent targets:
- Lisa Gill from JP Morgan set a target price of $420.0 on 04/28/2026
- Ryan Langston from TD Cowen set a target price of $337.0 on 04/23/2026
- Michael Wiederhorn from Oppenheimer set a target price of $405.0 on 04/22/2026
- Whit Mayo from Leerink Partners set a target price of $400.0 on 04/22/2026
- Ben Hendrix from RBC Capital set a target price of $400.0 on 04/22/2026
- Stephen Baxter from Wells Fargo set a target price of $397.0 on 04/22/2026
- David Toung from Argus Research set a target price of $400.0 on 04/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
